Search for: "Brian Cordery"
Results 21 - 28
of 28
Sorted by Relevance
|
Sort by Date
4 Mar 2019, 8:44 am
Brian Cordery and Laura ReynoldsOn Friday 1 March 2019, Arnold J handed down his judgment in the patent dispute between Eli Lilly and Genentech regarding IL-17A/F antibodies*1. [read post]
3 Apr 2018, 7:15 am
Brian Cordery and Rachel MumbyWise readers will know that when it comes to matters of the heart, it is often best not to interfere. [read post]
16 Jan 2018, 2:15 am
Brian Cordery and Gregory Baconby Greg Bacon There has been much excitement and comment amongst the UK patent profession following the Supreme Court’s decision in Actavis v Eli Lilly [2017] UKSC 48 (see previous comment here) on patent claim construction. [read post]
10 Oct 2011, 12:31 am
The first asked if anyone knew about this 'mystery case'; the second, later that same day, posted all the necessary information about it, thanks to Brian Cordery (Bristows). [read post]
4 Dec 2017, 7:18 am
Brian Cordery and Rachel MumbyWhilst many in show business have long lived by the adage “never work with children or animals” for fear of what might ensue, patent litigators in the UK have long been known to take a similar approach to experiments, avoiding them if at all possible for fear of the results. [read post]
14 Dec 2022, 11:59 pm
Kluwer IP Law interviewed Brian Cordery, partner at UK law firm Bristows, about his expectations. [read post]
14 Nov 2018, 8:14 am
Brian Cordery, Claire Phipps-Jones, Adrian Chew and Emma MunceyToday, after nine months of waiting, the decision of the UK Supreme Court in the pregabalin litigation was handed down. [read post]
18 Nov 2016, 12:44 am
The case also provides a useful comparator for the England and Wales Court of Appeal’s judgment on 13 October 2016 in Warner-Lambert Company LLC v Generics (UK) Ltd (t/a Mylan) & Ors [2016] EWCA Civ 1006 (EWCA Judgment) (covered by Brian Cordery of Bristows in ‘Pain and Plausibility – the Lyrica Appeal’), particularly with respect to how Australian and English law determine sufficiency and infringement of Swiss-style claims. [read post]
